No association of the G972S polymorphism of the insulin receptor substrate-1 gene with polycystic ovary syndrome in lean PCOS women with biochemical hyperandrogenemia

Archives of Gynecology and Obstetrics

Volumn 281, Issue 6, 2010, Pages 1045-1049

  Marioli, Dimitra J ^a   Koika, Vasiliki ^a   Adonakis, George L ^a   Saltamavros, Alexandros D ^a   Karela, Anastasia ^a   Armeni, Anastasia K ^a   Tsapanos, Vasilios S ^a   Decavalas, George O ^a   Georgopoulos, Neoklis A ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Hyperandrogenemia; Insulin receptor substrate 1; IRS 1 gene polymorphism; Lean PCOS women; Polycystic ovary syndrome

Indexed keywords

ANDROSTENEDIONE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GLUCOSE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PHENOTYPE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; FEMALE; GENOTYPE; GREECE; HUMANS; HYPERANDROGENISM; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; THINNESS; YOUNG ADULT;

EID: 77953651627     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-009-1299-2     Document Type: Article

References (25)

1. R Azziz E Carmina D Dewailly, et al. 2006 Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline J Clin Endocrinol Metab 91 11 4237 4245 10.1210/jc.2006-0178 1:CAS:528:DC%2BD28Xht1WhurzN 16940456 (Pubitemid 44833391)
2. E Carmina RA Lobo 1999 Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women J Clin Endocrinol Metab 84 1897 1899 10.1210/jc.84.6.1897 1:CAS:528: DyaK1MXjs1Oiurg%3D 10372683
3. A Dunaif 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis Endocr Rev 18 774 800 10.1210/er.18.6.774 1:CAS:528:DyaK1cXkvFel 9408743 (Pubitemid 28009567)
4. F Ovalle R Azziz 2002 Insulin resistance, polycystic ovary syndrome, and type II diabetes mellitus Fertil Steril 77 6 1095 1105 10.1016/S0015-0282(02) 03111-4 12057712 (Pubitemid 34626313)
5. A Dunaif KR Segal W Futterweit A Dorjansky 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome Diabetes 38 1164 1174 10.2337/diabetes.38.9.1165
6. CR Kahn 1994 Banting lecture: insulin action, diabetogenes, and the cause of type II diabetes Diabetes 43 1066 1084 10.2337/diabetes.43.4.587 1:CAS:528:DyaK2cXlsFCht78%3D 8039601
7. AM Venkatesan A Dunaif A Corbould 2001 Insulin resistance in polycystic ovary syndrome: progress and paradoxes Recent Prog Horm Res 56 295 308 10.1210/rp.56.1.295 1:CAS:528:DC%2BD3MXitV2lu7c%3D 11237218 (Pubitemid 36068065)
8. G Sesti M Federici ML Hribal D Lauro P Sbraccia R Lauro 2001 Defects of the insulin receptor substrate (IRS) system in human metabolic disorders FASEB 15 2099 2111 10.1096/fj.01-0009rev 1:CAS:528:DC%2BD3MXnsV2msbw%3D (Pubitemid 32927927)
9. K Almind C Bjorbaek H Vestergaard T Hansen SM Echwald O Pedersen 1993 Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes Lancet 342 828 832 10.1016/0140-6736(93)92694-O 1:STN:280: DyaK3szptVWktA%3D%3D 8104271 (Pubitemid 23285910)
10. GA Hitman K Hawrami MI McCarthy, et al. 1995 Insulin receptor substrate-1 gene mutations in NIDDM: implications for the study of polygenic disease Diabetologia 38 481 486 10.1007/BF00410287 1:STN:280:DyaK2MzhslGjug%3D%3D 7796990
11. AJ McGettrick EP Feeners CR Kahn 2005 Human Insulin receptor substrate-1 (IRS-1) polymorphism G972S causes IRS-1 to associate with the insulin receptor and inhibit receptor autophosphorylation JBC 280 8 6441 6446 10.1074/jbc.M412300200 1:CAS:528:DC%2BD2MXhsV2qs74%3D (Pubitemid 40341191)
12. SA El Mkadem C Lautier F Macari, et al. 2001 Role of allelic variants G972S of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome Diabetes 50 2164 2168 10.2337/diabetes.50.9.2164 1:CAS:528:DC%2BD3MXmsFKnsLk%3D 11522686
13. G Villuendas JI Botella-Carretero B Roldán J Sancho HF Escobar-Morreale JL San Millán 2005 Polymorphisms in the insulin receptor substrate-1 (IRS-1) gene and the insulin receptor substrate-2 (IRS-2) gene influence glucose homeostasis and body mass index in women with polycystic ovary syndrome and non-hyperandrogenic controls Hum Reprod 20 11 3184 3191 10.1093/humrep/dei205 1:CAS:528:DC%2BD2MXht1Cns77E 16037106 (Pubitemid 41662676)
14. DA Ehrmann X Tang I Yoshiuchi NJ Cox GI Bell 2002 Relationship of insulin receptor substrate-1 and-2 genotypes to phenotypic features of polycystic ovary syndrome J Clin Endocrinol Metab 87 9 4297 4300 10.1210/jc.2002-020216 1:CAS:528:DC%2BD38XntFOlsLc%3D 12213887
15. T Sir-Petermann F Pérez-Bravo B Angel M Maliqueo M Calvillan A Palomino 2001 G972S polymorphism of the IRS-1 in women with polycystic ovary syndrome Diabetologia 44 9 1200 1201 10.1007/s001250170001 1:CAS:528: DC%2BD3MXmtlWlt7k%3D 11596679 (Pubitemid 32835516)
16. Zawadski JK, Dunaif A (1992) Diagnostic criteria for polycystic ovary syndrome. In: Dunaif A, Givens JR, Haseltine FP, Merriam GE (eds) Polycystic ovary syndrome. Blackwell, Boston, pp 377-384
17. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on the diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril 81(1): 19-25
18. DR Mathews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner 1985 Homeostasis model assessment: insulin resistance and B cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412 419 10.1007/BF00280883 (Pubitemid 15018832)
19. E Carmina RA Lobo 2004 Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome Fertil Steril 82 661 665 10.1016/j.fertnstert.2004.01.041 15374711 (Pubitemid 39243189)
20. RM Bezerra V de Castro T Sales, et al. 2002 The G972S Polymorphism in insulin receptor substrate-1 is associated with decreased birth weight in a population-based sample of Brazilian newborns Diabetes Care 25 550 553 10.2337/diacare.25.3.550 1:CAS:528:DC%2BD38XitlWqtLo%3D 11874945 (Pubitemid 41103351)
21. RJ Norman D Dewailly RS Legro TE Hickey 2007 Polycystic ovary syndrome Lancet 370 685 697 10.1016/S0140-6736(07)61345-2 1:CAS:528:DC%2BD2sXpsFWrtrk%3D 17720020 (Pubitemid 47285318)
22. J Holte T Berg C Berne L Berglund H Lithell 1994 Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance J Clin Endocrinol Metab 78 1052 1058 10.1210/jc.78.5.1052 1:STN:280:DyaK2c3jtVKltw%3D%3D 8175959 (Pubitemid 24143022)
23. E Araki AL Myra M Patti, et al. 1994 Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene Nature 372 186 189 10.1038/372186a0 1:CAS:528:DyaK2cXmvFehu7Y%3D 7526222 (Pubitemid 24347839)
24. JC Brüning J Winnay B Cheatham CR Kahn 1997 Differential signalling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1 deficient mice Mol Cell Biol 17 1513 1521 9032279
25. M Urbanek RS Legro DA Driscoll, et al. 1999 Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin Proc Natl Acad Sci USA 96 8573 8587 10.1073/pnas.96.15.8573 1:CAS:528:DyaK1MXkslOktrY%3D 10411917 (Pubitemid 29354833)